A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus
Open Access
- 21 March 2024
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 206 (3) , e0033523
Abstract
Mycobacterium abscessus is increasingly recognized for causing infections that are notoriously difficult to treat, owing to its large arsenal of intrinsic antibiotic resistance mechanisms. Tools for the genetic manipulation of the pathogen are critical for enabling a better understanding of M. abscessus biology, pathogenesis, and antibiotic resistance mechanisms. However, existing methods are largely recombination-based, which are relatively inefficient. Meanwhile, CRISPR/Cas9 has revolutionized the field of genome editing including its recent adaptation for use in mycobacteria. In this study, we report a streamlined and efficient method for rapid genetic disruptions in M. abscessus . Harnessing the CRISPR1 loci from Streptococcus thermophilus , we have developed a dual-plasmid workflow that introduces Cas9 and sgRNA cassettes in separate steps but requires no other additional factors to engineer mutations in single genes or multiple genes simultaneously or sequentially using multiple targeting sgRNAs. Importantly, the efficiency of mutant generation is several orders of magnitude higher than reported for homologous recombination-based methods. This work, thus, reports the first application of CRISPR/Cas9 for gene editing in M. abscessus and is an important tool in the arsenal for the genetic manipulation of this human pathogen. IMPORTANCE: Mycobacterium abscessus is an opportunistic pathogen of increasing clinical importance due to its poor clinical outcomes and limited treatment options. Drug discovery and development in this highly antibiotic-resistant species will require further understanding of M. abscessus biology, pathogenesis, and antibiotic resistance mechanisms. However, existing methods for facile genetic engineering are relatively inefficient. This study reports on the first application of CRISPR/Cas9 for gene editing in M. abscessus using a dual-plasmid workflow. We establish that our method is easily programmable, efficient, and versatile for genetic disruptions in M. abscessus . This is a critical advancement to facilitating targeted gene function studies in this emerging pathogen.Keywords
Funding Information
- Broad Institute Tuberculosis Donor Group
- Pershing Square Foundation
This publication has 33 references indexed in Scilit:
- Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genesJournal of Antimicrobial Chemotherapy, 2017
- Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platformNature Microbiology, 2017
- Intrinsic rifamycin resistance ofMycobacterium abscessusis mediated by ADP-ribosyltransferase MAB_0591Journal of Antimicrobial Chemotherapy, 2016
- Infections caused byMycobacterium abscessus: epidemiology, diagnostic tools and treatmentExpert Review of Anti-infective Therapy, 2016
- Investigating essential gene function inMycobacterium tuberculosisusing an efficient CRISPR interference systemNucleic Acids Research, 2016
- Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly ImprovementPLOS ONE, 2014
- Mycobacterium abscessus: a new antibiotic nightmareJournal of Antimicrobial Chemotherapy, 2012
- Genetic Manipulation of Mycobacterium abscessusCurrent Protocols in Microbiology, 2010
- Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red ReportersPLOS ONE, 2010
- Construction of Mycobacterium abscessus Defined Glycopeptidolipid Mutants: Comparison of Genetic ToolsApplied and Environmental Microbiology, 2009